EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2009. Start Trial.
Date Value
December 31, 2024 -0.1169
September 30, 2024 -0.1765
June 30, 2024 -0.514
March 31, 2024 0.089
December 31, 2023 -0.052
September 30, 2023 -0.039
June 30, 2023 -0.067
March 31, 2023 -0.169
December 31, 2022 -0.137
September 30, 2022 -0.151
June 30, 2022 -0.052
March 31, 2022 0.013
December 31, 2021 0.396
September 30, 2021 -0.151
June 30, 2021 -0.218
March 31, 2021 0.054
December 31, 2020 -0.8428
September 30, 2020 -0.7215
June 30, 2020 -0.868
March 31, 2020 0.1362
December 31, 2019 -0.216
September 30, 2019 -0.244
June 30, 2019 -0.555
March 31, 2019 0.753
December 31, 2018 0.204
Date Value
September 30, 2018 0.20
June 30, 2018 0.007
March 31, 2018 0.17
December 31, 2017 -0.001
September 30, 2017 0.30
June 30, 2017 -0.30
March 31, 2017 -0.30
December 31, 2016 -0.40
September 30, 2016 -0.10
June 30, 2016 -0.20
March 31, 2016 -0.20
December 31, 2015 -0.90
September 30, 2015 -0.20
June 30, 2015 -0.20
March 31, 2015 -0.50
December 31, 2014 -0.40
September 30, 2014 -0.20
June 30, 2014 -0.20
March 31, 2014 -0.30
December 31, 2013 -0.50
September 30, 2013 0.20
June 30, 2013 -0.40
March 31, 2013 -0.40
December 31, 2012 -0.10
September 30, 2012 -0.022

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
BioLineRx Ltd. -0.6957
Kamada Ltd. 0.1605
Can-Fite BioPharma Ltd. --
Eocene Ltd. -2.860
Revium Recovery, Inc. -0.0096